__timestamp | HUTCHMED (China) Limited | Vertex Pharmaceuticals Incorporated |
---|---|---|
Wednesday, January 1, 2014 | 91813000 | 580415000 |
Thursday, January 1, 2015 | 178203000 | 1032336000 |
Friday, January 1, 2016 | 216080000 | 1702177000 |
Sunday, January 1, 2017 | 241203000 | 2488652000 |
Monday, January 1, 2018 | 214109000 | 3047597000 |
Tuesday, January 1, 2019 | 204890000 | 4162821000 |
Wednesday, January 1, 2020 | 227976000 | 6205683000 |
Friday, January 1, 2021 | 356128000 | 7574400000 |
Saturday, January 1, 2022 | 426409000 | 8930700000 |
Sunday, January 1, 2023 | 837999000 | 9869200000 |
Monday, January 1, 2024 | 11020100000 |
In pursuit of knowledge
In the dynamic world of pharmaceuticals, revenue growth is a key indicator of success. Over the past decade, Vertex Pharmaceuticals Incorporated has demonstrated a remarkable trajectory, with its revenue surging by over 1,600% from 2014 to 2023. This growth is a testament to Vertex's innovative approach and successful product launches. In contrast, HUTCHMED (China) Limited, while showing a steady increase, has experienced a more modest growth of approximately 800% during the same period.
The data reveals that Vertex's revenue in 2023 is nearly 12 times that of HUTCHMED, highlighting the competitive landscape of the pharmaceutical industry. This comparison not only underscores the importance of strategic innovation but also the varying market dynamics faced by companies in different regions. As we look to the future, these trends offer valuable insights into the evolving pharmaceutical market.
Revenue Showdown: Novo Nordisk A/S vs HUTCHMED (China) Limited
Comparing Revenue Performance: Sanofi or HUTCHMED (China) Limited?
Bristol-Myers Squibb Company vs HUTCHMED (China) Limited: Examining Key Revenue Metrics
Vertex Pharmaceuticals Incorporated and argenx SE: A Comprehensive Revenue Analysis
Vertex Pharmaceuticals Incorporated or Jazz Pharmaceuticals plc: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Vertex Pharmaceuticals Incorporated or Pharming Group N.V.?
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Corcept Therapeutics Incorporated
Revenue Insights: Vertex Pharmaceuticals Incorporated and ACADIA Pharmaceuticals Inc. Performance Compared
Revenue Insights: Vertex Pharmaceuticals Incorporated and Evotec SE Performance Compared
Revenue Insights: Vertex Pharmaceuticals Incorporated and Xencor, Inc. Performance Compared
Annual Revenue Comparison: ADMA Biologics, Inc. vs HUTCHMED (China) Limited
Annual Revenue Comparison: Merus N.V. vs HUTCHMED (China) Limited